H.R. 6043 - Fair Accountability and Innovative Research Drug Pricing Act of 2016
- Sponsor:
- Janice D. Schakowsky
- Summary:
- To require reporting regarding certain drug price increases, and for other purposes. (by CRS)
- Status:
- The bill has been referred to committee.
Fair Accountability and Innovative Research Drug Pricing Act of 2016
H.R. 6043 — 114th Congress (2015–2016)
- Summary
- To require reporting regarding certain drug price increases, and for other purposes. (by CRS)
- Learn More
- At OpenCongress
- Title
- To require reporting regarding certain drug price increases, and for other purposes.
- Other Titles
- Fair Accountability and Innovative Research Drug Pricing Act of 2016
- Fair Accountability and Innovative Research Drug Pricing Act of 2016
- Sponsor
- Janice D. Schakowsky
- Co-Sponsors
- Subjects
- Health
- Civil actions and liability
- Congressional oversight
- Consumer affairs
- Corporate finance and management
- Government information and archives
- Government studies and investigations
- Inflation and prices
- Medical research
- Prescription drugs
- Research and development
- Related Bills
- Major Actions
Introduced 9/15/2016 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 9/15/2016 9/15/2016 Introduced in House 9/15/2016 Referred to the House Committee on Energy and Commerce. Number Sponsor Date Offered Status
Total contributions given to House members from interest groups that…
supported this bill
Contributions data source: OpenSecrets.org